Certican 0.75mg tablet

Description

Certican 0.75mg (60 tablets) contains the active ingredient everolimus,

an immunosuppressant used to prevent organ Certican 0.75mg price rejection in adult kidney and heart transplant patients.

It works by inhibiting mTOR kinase, reducing the body’s immune response, and is typically used in Certican 0.75mg online combination with ciclosporin and corticosteroids.

Everolimus (0.75 mg)Category of Drug: mTOR kinase inhibitor / Immuno suppressant Appearance of the Drug: White to yellowish, marbled, round, flat tablets (8.5 mm), often marked with the inscription “CL” on one side, and “NVR” on the other Side Effects: Prophylactic (preventive) therapy for rejection of allogeneic organs (kidney, heart, liver) in adults Therapy for advanced types of oncological and neoplastic diseases, including breast cancer, neuroendocrine tumors, renal cell carcinoma (often administered as part of combination therapy)Pharmacological Actions.

Everolimus is a proliferation signal inhibitor. It acts by interacting with cytoplasmic protein FKBP-12 forming complex that deactivates FRAP (m-TOR), thus inhibiting the regulatory protein controlling cellular metabolism and proliferation. Everolimus blocks activated by antigenic stimulation T-cells at the G₁ phase, thereby stopping clonal proliferation and organ rejection.

Dose administration: Take the tablet whole with a full glass of water; don’t crush or chew it .Interactions with Food: May be taken both with and without meals; but consistent approach is essential; you should always take the drug under the same conditions (always with food or always without).

Everolimus is an oral prescription medicine that acts by suppressing the body’s immune responses and hindering excessive cell proliferation. Its use is mainly indicated for prevention of transplantation rejection.